By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed Pharmaceuticals, Inc. (OMED) To Webcast 2015 Research And Development Day On April 29, 2015 4/23/2015 11:06:05 AM
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Dosing In Randomized Phase 2 Clinical Trial Of Demcizumab In Pancreatic Cancer Patients 4/22/2015 7:49:37 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data On Clinical And Preclinical Anti-Cancer Stem Cell Programs At AACR Annual Meeting 4/21/2015 11:23:56 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Abstracts Accepted For Presentation At The 2015 ASCO Annual Meeting 4/21/2015 10:27:43 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Demcizumab Data From Phase 1b Clinical Trial In Non-Small Cell Lung Cancer Patients At The European Lung Cancer Conference 4/16/2015 9:01:32 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Needham Healthcare Conference 4/10/2015 8:44:27 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical Data For Demcizumab At The European Lung Cancer Conference 4/9/2015 7:43:03 AM
OncoMed Pharmaceuticals, Inc. (OMED) And Eli Lilly (LLY) Enter Clinical Supply Agreement To Evaluate The Combination Of Demcizumab And Alimta (Pemetrexed For Injection) In Lung Cancer 4/2/2015 7:09:38 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Data On Multiple Anti-Cancer Stem Cell Candidates At The American Association for Cancer Research Meeting 3/19/2015 7:48:33 AM
OncoMed Pharmaceuticals, Inc. (OMED) Reports Full Year And Fourth Quarter 2014 Financial Results And Recent Highlights 3/13/2015 7:21:41 AM
12345678910...
//-->